Results 231 to 240 of about 2,180,284 (400)

Limited willingness to switch from intravenous to subcutaneous treatment in paediatric inflammatory bowel disease. [PDF]

open access: yesBMJ Paediatr Open
Eindor-Abarbanel A   +11 more
europepmc   +1 more source

Experimental induction of rheumatoid factor and joint lesions in rabbits after intravenous injections of killed bacteria.

open access: yesAnnals of the Rheumatic Diseases, 1986
A. Hanglow   +5 more
semanticscholar   +1 more source

PD‐1 Inhibits CD4+ TRM‐Mediated cDC1 Mobilization via Suppressing JAML in Human NSCLC

open access: yesAdvanced Science, EarlyView.
CD4+ tissue‐resident memory T cells (TRMs) in non‐small cell lung cancer recruit conventional type 1 dendritic cells via XCL1‐XCR1 signaling, orchestrating antitumor immunity. The costimulatory molecule JAML is essential for this process. PD‐1 blockade restores JAML expression and cDC1 mobilization, while JAML agonists synergize with anti‐PD‐1 therapy,
Zheyu Shao   +16 more
wiley   +1 more source

Regulating Tumor Metabolic Reprogramming with Biomimetic Co‐Delivery of Simvastatin and Kynureninase for Immunotherapy

open access: yesAdvanced Science, EarlyView.
After the intravenous injection of biomimetic and pH/ROS‐responsive PTSK@CRM, the nanoparticles can be accumulated in tumors and release Sim and KYNase to inhibit the tumor growth, regulate the metabolism of cholesterol and Kyn, and reverse the immunosuppressive tumor microenvironment.
Jiaxin Yin   +6 more
wiley   +1 more source

MEASUREMENT OF GLUCOSE DISPOSAL RATES IN NORMAL AND DIABETIC HUMAN SUBJECTS AFTER REPEATED INTRAVENOUS INJECTIONS OF GLUCOSE.

open access: yesJournal of Clinical Endocrinology and Metabolism, 1964
D. Streeten   +3 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy